$1.410
+0.041 (+2.92%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de PRQR por análisis de gráficos similares
Alphio's PRQR stock price prediction model matches the current ProQR Therapeutics NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.34 (+0.59%). The 1-week path is $1.34 (+0.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de ProQR Therapeutics NV?
ProQR Therapeutics is currently trading at $1.32, significantly below its 52-week high of $2.65, indicating potential upside. However, the stock has a low RSI of 39.15, suggesting it is nearing oversold territory, but it also reflects weak momentum. The company has a gross margin of 100%, which is excellent, but it has reported consistent net losses, with a net income loss of €13,383,000 in Q1 2026. The main risk is the company's ongoing financial losses and reliance on external financing, as evidenced by a recent direct offering that caused a 20% drop in share price. Given these factors, it may be prudent to hold rather than buy at this time, as the stock may need to stabilize before a clear buying opportunity arises.
PRQR cerró en $1.41 el Wednesday, tras subir +2.92%
ProQR Therapeutics NV (PRQR) last closed at $1.335, losing -5.32%. These facts feed the 1-day and 1-week PRQR price prediction above.
Consenso de analistas
ProQR Therapeutics NV (PRQR): 3 comprar, 1 mantener, 0 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de ProQR Therapeutics NV (PRQR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de PRQR, ordenadas por similitud.
Análisis de estacionalidad de PRQR
Historically the probability of a positive November return for PRQR is 46.51%. December offers the highest probability of a positive month at 48.84%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de PRQR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.23 | $2.01 | $2.85 | +50.91% |
| Dec 2026 | $1.58 | $1.82 | $2.08 | +36.00% |
En 2026, se proyecta que ProQR Therapeutics NV (PRQR) oscile entre $1.23 y $2.85.
Previsión mensual de ProQR Therapeutics NV para 2026
En Nov de 2026, se proyecta que ProQR Therapeutics NV promedie $2.01, con un mínimo de $1.23 y un máximo de $2.85.
En Dec de 2026, se proyecta que ProQR Therapeutics NV promedie $1.82, con un mínimo de $1.58 y un máximo de $2.08.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.